This content is machine translated Metastatic renal cell carcinoma (mRCC) Individual therapy management improves treatment success Increasing understanding of the pathogenetic relationships of renal cell carcinoma has contributed to the development of new drugs. These specifically interfere with the VEGF, PDGF and mTOR signaling pathways. In…
